Clarity Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
1,021
+8
+0.8% +$1.86K 0.13% 60
2026
Q1
$248K Sell
1,013
-136
-12% -$31.7K 0.13% 60
2025
Q4
$238K Buy
1,149
+3
+0.3% +$593 0.13% 36
2025
Q3
$212K Buy
1,146
+9
+0.8% +$1.54K 0.12% 37
2025
Q2
$174K Sell
1,137
-1
-0.1% -$154 0.1% 42
2025
Q1
$189K Sell
1,138
-296
-21% -$46.3K 0.12% 36
2024
Q4
$207K Buy
1,434
+12
+0.8% +$1.86K 0.14% 32
2024
Q3
$230K Buy
1,422
+7
+0.5% +$1.11K 0.16% 29
2024
Q2
$207K Buy
1,415
+32
+2% +$4.76K 0.15% 32
2024
Q1
$219K Buy
1,383
+1
+0.1% +$159 0.15% 32
2023
Q4
$217K Buy
+1,382
New +$212K 0.17% 30

Other funds holding JNJ

Clarity Asset Management's JNJ Position: Q2 2026 in Review

Clarity Asset Management increased its Johnson & Johnson (JNJ) stake by 0.79% in Q2 2026, buying an estimated $1.86K and bringing the position to 1,021 shares worth $259K. The position accounts for 0.13% of the portfolio, ranked #60.

Clarity Asset Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clarity Asset Management held 1,021 shares of Johnson & Johnson worth $259K as of Q2 2026.
  • Clarity Asset Management bought 8 Johnson & Johnson shares in Q2 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.13% of Clarity Asset Management's portfolio in Q2 2026, its #60 holding.
  • Clarity Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clarity Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.